Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies

被引:29
作者
Li, Xin [1 ]
Wen, Song-Nan [1 ]
Li, Song-Nan [1 ]
Bai, Rong [1 ]
Liu, Nian [1 ]
Feng, Li [1 ]
Ruan, Yan-Fei [1 ]
Du, Xin [1 ]
Dong, Jian-Zeng [1 ]
Ma, Chang-Sheng [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Natl Clin Res Ctr Cardiovasc Dis, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
基金
美国国家科学基金会;
关键词
Atrial fibrillation; Stroke prevention; Left atrial appendage occlusion; Novel oral anticoagulant; Meta-analysis; AMPLATZER CARDIAC PLUG; SINGLE-CENTER EXPERIENCE; WATCHMAN DEVICE; CLOSURE; DABIGATRAN; WARFARIN; CONTRAINDICATIONS; THERAPY; REDUCE; TERM;
D O I
10.1016/j.hrthm.2015.12.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND A direct comparison of the efficacy and safety profiles of left atrial appendage occlusion (LAAO) devices and novel oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation is warranted but currently unavailable. OBJECTIVE The aim of this study was to compare the >1-year efficacy and safety of LAAO devices and NOACs for stroke prevention in patients with atrial fibrillation. METHODS We performed a systematic review on randomized controlled trials (RCTs) and observational studies. RCTs were analyzed by means of a network meta-analysis method using warfarin as a bridge to compare LAAO to individual NOAC or all NOACs as a whole. Observational studies were analyzed with the meta-proportion function where pooled event rates were compared. RESULTS A total of 6 RCTs and 27 observational studies were included. A network meta-analysis of RCTs indicated that LAAO was less effective than NOACs for stroke prevention (odds ratio 0.86), but had a lower rate of hemorrhagic events during follow-up. However, a meta-proportion analysis of observational studies revealed that LAAO devices were associated with a lower rate of both thromboembolic events (1.8 events per 100 patient-years vs 2.4 events per 100 patient years) and major bleeding events during follow-up (2.2 events per 100 patient-years vs 2.5 events per 100 patient-years) as compared with NOACs. With prolonged follow-up duration after LAAO implantation, the rate of thromboembolic events decreased (2.1, 1.8, and 1.0 events per 100 person-years for 1, 1-2, and >2 years, respectively). CONCLUSION Although superiority of LAAO over NOACs was not demonstrated by RCTs in terms of stroke prevention, LAAO was found to be consistently associated with a lower rate of both thromboembolic and hemorrhagic events as compared with NOACs in observational studies.
引用
收藏
页码:1203 / 1214
页数:12
相关论文
共 38 条
[1]   Dabigatran use in elderly patients with atrial fibrillation [J].
Avgil-Tsadok, Meytal ;
Jackevicius-, Cynthia A. ;
Essebag, Vidal ;
Eisenberg, Mark J. ;
Rahme, Elham ;
Behlouli, Hassan ;
Pilote, Louise .
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (01) :152-160
[2]   Intraprocedural and Long-Term Incomplete Occlusion of the Left Atrial Appendage Following Placement of the WATCHMAN Device: A Single Center Experience [J].
Bai, Rong ;
Horton, Rodney P. ;
Di Biase, Luigi ;
Mohanty, Prasant ;
Pump, Agnes ;
Cardinal, Deb ;
Scallon, Chantel ;
Mohanty, Sanghamitra ;
Santangeli, Pasquale ;
Brantes, Mauricio C. ;
Sanchez, Javier ;
Burkhardt, J. David ;
Zagrodzky, Jason D. ;
Gallinghouse, G. Joseph ;
Natale, Andrea .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (05) :455-461
[3]   Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation Results from the Dresden NOAC Registry [J].
Beyer-Westendorf, Jan ;
Ebertz, Franziska ;
Foerster, Kati ;
Gelbricht, Vera ;
Michalski, Franziska ;
Koehlerl, Christina ;
Werth, Sebastian ;
Endig, Heike ;
Pannach, Sven ;
Tittl, Luise ;
Sahin, Kurtulus ;
Daschkow, Katharina ;
Weiss, Norbert .
THROMBOSIS AND HAEMOSTASIS, 2015, 113 (06) :1247-1257
[4]   Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation [J].
Blackshear, JL ;
Odell, JA .
ANNALS OF THORACIC SURGERY, 1996, 61 (02) :755-759
[5]  
Boston Scientific Corporation, SUMM SAF EFF DAT SSE
[6]   XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation [J].
Camm, A. John ;
Amarenco, Pierre ;
Haas, Sylvia ;
Hess, Susanne ;
Kirchhof, Paulus ;
Kuhls, Silvia ;
van Eickels, Martin ;
Turpie, Alexander G. G. .
EUROPEAN HEART JOURNAL, 2016, 37 (14) :1145-1153
[7]   Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation [J].
Chan, Pak-Hei ;
Huang, Duo ;
Hai, Jo Jo ;
Li, Wen-Hua ;
Yin, Li-Xue ;
Chan, Esther W. ;
Wong, Ian C. K. ;
Lau, Chu-Pak ;
Chiang, Chern-En ;
Zhu, Jun ;
Tse, Hung-Fat ;
Siu, Chung-Wah .
HEART RHYTHM, 2016, 13 (02) :366-373
[8]   Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: A prospective single-center experience [J].
Chun, K. R. Julian ;
Bordignon, Stefano ;
Urban, Verena ;
Perrotta, Laura ;
Dugo, Daniela ;
Fuernkranz, Alexander ;
Nowak, Bernd ;
Schmidt, Boris .
HEART RHYTHM, 2013, 10 (12) :1792-1799
[9]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[10]   Does Left Atrial Appendage Closure with a Cardiac Plug System Reduce the Stroke Risk in Nonvalvular Atrial Fibrillation Patients? A Single-Center Case Series [J].
Danna, Paolo ;
Proietti, Riccardo ;
Sagone, Antonio ;
Arensi, Andrea ;
Viecca, Maurizio ;
Rago, Anna ;
Russo, Vincenzo .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (03) :347-353